QLGN vs CLSD
Comparison between Qualigen Therapeutics, Inc. Common Stock (QLGN, Company) and Clearside Biomedical, Inc. Common Stock (CLSD, Company).
Both QLGN and CLSD are from the Healthcare sector.
5-Year PerformanceCLSD has outperformed QLGN, delivering a return of -64.5% compared to -74.3%
QLGN vs CLSD - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
QLGN vs CLSD - Historical Returns
Returns include dividend reinvestment.
QLGN vs CLSD - Annual Returns (2015 - 2026)
Returns include dividend reinvestment.
| Year | QLGN | CLSD |
|---|---|---|
| 2026 | -50.42% | +0.00% |
| 2025 | -44.30% | -97.14% |
| 2024 | -84.80% | -26.36% |
| 2023 | -60.14% | -3.70% |
| 2022 | -89.08% | -61.11% |
| 2021 | -66.03% | -14.20% |
| 2020 | -41.84% | +29.86% |
| 2019 | -79.81% | +152.17% |
| 2018 | -80.77% | -85.12% |
| 2017 | -88.62% | -25.29% |
| 2016 | +66.26% | +23.31% |
| 2015 | -65.73% | N/A |
QLGN vs CLSD Drawdown Comparison
The maximum drawdown for QLGN was -100.00%, occurring on Feb 24, 2026. This drawdown has not yet recovered.
The maximum drawdown for CLSD was -99.89%, occurring on Nov 28, 2025. This drawdown has not yet recovered.
The current QLGN drawdown is -100.00%. The current CLSD drawdown is -99.89%.
| Rank | QLGN | CLSD |
|---|---|---|
| #1 | -100.00% Jun 24, 2015 - Feb 24, 2026 | -99.89% Oct 11, 2016 - Nov 28, 2025 |
| #2 | N/A | -17.17% Jun 2, 2016 - Aug 23, 2016 |
| #3 | N/A | -5.93% Sep 28, 2016 - Oct 3, 2016 |
| #4 | N/A | -5.91% Aug 23, 2016 - Aug 30, 2016 |
| #5 | N/A | -5.71% Sep 9, 2016 - Sep 19, 2016 |
| #6 | N/A | -4.10% Oct 3, 2016 - Oct 5, 2016 |
| #7 | N/A | -1.45% Sep 7, 2016 - Sep 9, 2016 |
| #8 | N/A | -1.09% Sep 21, 2016 - Sep 23, 2016 |
| #9 | N/A | -1.07% Aug 30, 2016 - Sep 1, 2016 |
| #10 | N/A | -0.67% Sep 2, 2016 - Sep 7, 2016 |
Correlation
Correlation between QLGN and CLSD is 0.68 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks